Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Other financing activities (2019 - 2024)

Dna X's Other financing activities history spans 4 years, with the latest figure at $472000.0 for Q2 2024.

  • Quarterly results put Other financing activities at $472000.0 for Q2 2024, up 31.84% from a year ago — trailing twelve months through Jun 2024 was $1.5 million (down 25.55% YoY), and the annual figure for FY2023 was $1.5 million, down 3.55%.
  • Other financing activities for Q2 2024 was $472000.0 at Dna X, up from $324000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.0 million in Q4 2022 to a low of $253000.0 in Q1 2022.
  • The 3-year median for Other financing activities is $324000.0 (2024), against an average of $430571.4.
  • Peak annual rise in Other financing activities hit 31.84% in 2024, while the deepest fall reached 4.85% in 2024.
  • Year by year, Other financing activities stood at $1.0 million in 2022, then crashed by 65.48% to $358000.0 in 2023, then skyrocketed by 31.84% to $472000.0 in 2024.
  • According to Business Quant data, Other financing activities over the past three periods came in at $472000.0, $324000.0, and $358000.0 for Q2 2024, Q1 2024, and Q2 2023 respectively.